31 related articles for article (PubMed ID: 2423239)
1. Combined treatment of advanced malignant melanoma with coumarin and cimetidine. A phase II study.
Pedersen L; Rose C; Langvad E
Cancer Immunol Immunother; 1987; 24(2):178-9. PubMed ID: 3829053
[TBL] [Abstract][Full Text] [Related]
2. Conceptual Knowledge Discovery in Databases for Drug Combinations Predictions in Malignant Melanoma.
Regan K; Raje S; Saravanamuthu C; Payne PR
Stud Health Technol Inform; 2015; 216():663-7. PubMed ID: 26262134
[TBL] [Abstract][Full Text] [Related]
3. Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy.
Singh BN; Malhotra BK
Clin Pharmacokinet; 2004; 43(15):1127-56. PubMed ID: 15568891
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for malignant melanoma: combinations and high doses produce more responses without survival benefit.
Lakhani S; Selby P; Bliss JM; Perren TJ; Gore ME; McElwain TJ
Br J Cancer; 1990 Feb; 61(2):330-4. PubMed ID: 1690022
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of the combination of vinblastine plus cisplatin administered by continuous 120-hour infusion for patients with advanced malignant melanoma.
Creagan ET; Ahmann DL; Schutt AJ; Schaid DJ
Cancer Treat Rep; 1987; 71(7-8):769-70. PubMed ID: 3607788
[No Abstract] [Full Text] [Related]
6. Phase II trial of vinblastine, bleomycin, and cisplatin (VBP) followed by dacarbazine and mitolactol in metastatic melanoma.
Richman SP; Woodcock TM; Kubota TT; Blumenreich MS; Gentile PS; Allegra JC
Cancer Treat Rep; 1984 Nov; 68(11):1395-6. PubMed ID: 6209008
[No Abstract] [Full Text] [Related]
7. Interleukin-2 plus chemotherapy for patients with metastatic melanoma.
Paciucci PA; Ryder JS; Mandell JP; Morris JC; Holland JF
Melanoma Res; 2000 Jun; 10(3):291-5. PubMed ID: 10890384
[TBL] [Abstract][Full Text] [Related]
8. Lomustine, vincristine, and procarbazine in the treatment of metastatic malignant melanoma.
Shelley W; Quirt I; Bodurtha A; Iscoe N; Russell J; Paterson A; Young V
Cancer Treat Rep; 1985 Sep; 69(9):941-4. PubMed ID: 2992784
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy of disseminated melanoma with bleomycin, vincristine, CCNU, and DTIC (BOLD regimen). The Prudente Foundation Melanoma Study Group.
Cancer; 1989 May; 63(9):1676-80. PubMed ID: 2467736
[TBL] [Abstract][Full Text] [Related]
10. Lomustine, bleomycin, and cisplatin in patients with metastatic malignant melanoma.
Cohen SM; Ohnuma T; Ambinder EP; Holland JF
Cancer Treat Rep; 1986 May; 70(5):688-9. PubMed ID: 2423239
[No Abstract] [Full Text] [Related]
11. [Chemotherapy of malignant melanoma].
Avril MF
Ann Dermatol Venereol; 1988; 115(9):959-68. PubMed ID: 2464963
[No Abstract] [Full Text] [Related]
12. [Chemotherapy of malignant melanoma].
Ishihara K
Gan To Kagaku Ryoho; 1995 Jan; 22(1):23-7. PubMed ID: 7529980
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]